SNSS - Sunesis Pharmaceuticals Inc. (SNSS) Q3 2020 Results - Earnings Call Transcript
Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results Conference Call November 16, 2020 04:30 PM ET Company Participants Par Hyare - SVP, Commercial Dayton Misfeldt - Dayton Misfeldt Judy Fox - Chief Scientific Officer and EVP, Research & Development Conference Call Participants Justin Kim - Oppenheimer and Company Nick Abbott - Wells Fargo Ernie Rodriguez - Cowen Presentation Operator Welcome to Sunesis Pharmaceuticals Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference may be recorded. [Operator instructions] I would now to turn the conference over to, Par Hyare, Senior Vice President, Commercial. Please go ahead, sir. Par Hyare Thank you. Welcome everyone and thank you for joining us today. With me on the call today are Dayton Misfeldt, Interim CEO; and Judy Fox, Chief Scientific Officer, EVP,
For further details see:
Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results - Earnings Call Transcript